Ross Prize in Molecular Medicine

The annual Ross Prize in Molecular Medicine is established in conjunction with the Feinstein Institutes for Medical Research and Molecular Medicine. The winner will be an active investigator having produced innovative, paradigm-shifting research that is worthy of significant and broad attention in the field of molecular medicine. We expect this individual will continue to garner recognition in future years, and that their current accomplishments reflect a rapidly rising career trajectory of discovery and invention. The winner will receive an honorarium of $50,000 USD, travel expenses to accept the award in New York, and will present the keynote lecture at the Award Ceremony and Mini-Symposium (traditionally held during the month of June).

For more information, please send an email to [email protected]. 

Jeffery W. Kelly, PhD, is the recipient of the 12th annual Ross Prize in Molecular Medicine for his contributions to the science of protein misfolding and aggregation in disease. Dr. Kelly has translated basic understanding of protein folding to create therapeutics designed to prevent disease-causing protein aggregation, including the discovery of the first-in-class small molecule drug called tafamidis. The Kelly lab is currently developing novel therapeutic strategies for degenerative diseases including Alzheimer's and Parkinson's diseases, and for loss-of-function diseases such as lysosomal storage diseases.

Please click here for more details about the 12th Ross Prize Symposium 2025: Protein Misfolding and Aggregation in Disease.

Ross Prize 2024: Michelle Monje, MD, PhD
Ross Prize 2023: Helen H. Hobbs, MD and Jonathan C. Cohen, PhD
Ross Prize 2022: Katalin Karikó, PhD and Drew Weissman, MD
Ross Prize 2020: Adrian R. Krainer, MD
Ross Prize 2019: Dan Kastner, MD, PhD
Ross Prize 2018: Huda Zoghbi, MD
Ross Prize 2017: Jeffrey V. Ravetch, MD, PhD
Ross Prize 2016: Charles N Serhan, PhD, DSc
Ross Prize 2015: Lewis C Cantley, MD
Ross Prize 2014: John J O'Shea, MD
Ross Prize 2013: Dan R Littman, MD, PhD

Qualified Nominators for The Ross Prize in Molecular Medicine
The right to submit nominations for the prize is enjoyed by contributing Editors, Corresponding authors of published articles and peer reviewers of Molecular Medicine. Members of National Academies, Medical School Deans and previous winners of the prize may also submit  nominations. Others may submit by invitation. To request an invitation, please email [email protected]. 

Nomination Timeline for The Ross Prize in Molecular Medicine
Below is a brief description of the timeline for the prize.

• November 17, 2025: Deadline for Nominations
• October - December 31, 2025: Application Review
• January 2026: Prize Awardee Notification
• Spring 2026: Prize Awardee Announcement
• June 2026: Thirteenth Annual Ross Prize in Molecular Medicine Symposium

Nomination Materials for The Ross Prize in Molecular Medicine Application
Candidates* eligible for the prize are those nominated by a Qualified Nominator as listed above. An individual may not nominate himself or herself. Qualified Nominators are required to submit the following materials for the nomination application:

1. A 1 or 2 page cover letter describing the reasons for nomination
2. A 2-4 page biosketch of the nominee in NIH format (or a similar format);
3. A full CV of the nominee; and
4. Reprints (PDFs) of up to 10 publications.

* In the event that two or more people are co-nominated, the award will be shared equally among the winners.

Note: An individual may not nominate himself or herself.

Betty Diamond, MD, Molecular Medicine
Peter K Gregersen, MD, The Feinstein Institutes for Medical Research
Lars Klareskog, MD, PhD, Karolinska Institutet
Klas Kärre, MD, PhD, Karolinska Institutet
Anna Wedell, MD, PhD, Karolinska Institutet
Valentin A Pavlov, PhD, The Feinstein Institutes for Medical Research
Kevin J Tracey, MD, The Feinstein Institutes for Medical Research